Company Profile
FEMASYS Stock Price, News & Analysis
- Ticker:
- FEMY
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, FEMASYS is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
4.01 USD (-1.72%)
Close
Last updated: June 23, 2026 at 00:00
12.11M USD
Market cap
Why the stock is moving
FEMY is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
FEMASYS is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, FEMASYS is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
FEMASYS follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, FEMASYS sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of FEMASYS (FEMY)?
FEMASYS (FEMY) most recently closed at 4.01 USD, a -1.72% move versus the previous session.
What is the market cap of FEMASYS (FEMY)?
FEMASYS currently has a market capitalization of 12.11M USD on BioPharmSignal.
What does FEMASYS do?
FEMASYS is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is FEMY stock listed?
FEMASYS (FEMY) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, FEMASYS is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is FEMASYS targeting with Investors?
FEMASYS is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.